Stockscreener 앱 받기
80.21
1.43%
-1.16
시간 외 거래:
80.21
전일 마감가:
$81.37
열려 있는:
$80.09
하루 거래량:
1.32M
Relative Volume:
1.00
시가총액:
$9.44B
수익:
$13.18B
순이익/손실:
$419.00M
주가수익비율:
24.53
EPS:
3.2704
순현금흐름:
$521.00M
1주 성능:
-3.77%
1개월 성능:
+9.67%
6개월 성능:
+19.48%
1년 성능:
+13.27%
1일 변동 폭
$78.79
$80.69
1주일 범위
$78.79
$83.36
52주 변동 폭
$60.56
$89.29
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
80.21 | 9.58B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
MCK
Mckesson Corporation
|
995.69 | 121.38B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
371.44 | 72.49B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
226.35 | 54.09B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
AHG
Akso Health Group Adr
|
1.4414 | 1.12B | 2.22M | -5.63M | -1.68M | -0.24 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Stanley Bergman Sells 43,812 Shares of Henry Schein (NASDAQ:HSIC) Stock - MarketBeat
Insider Selling: Stanley M Bergman Unloads $3.56M Of Henry Schein Stock - Benzinga
Henry Schein Insider Sold Shares Worth $3,562,354, According to a Recent SEC Filing - marketscreener.com
Henry Schein (HSIC) CFO disposes shares, covers tax on vested stock - Stock Titan
Henry Schein (HSIC) HR chief disposes shares to cover equity award taxes - Stock Titan
Henry Schein (HSIC) executive surrenders shares, including tax-withholding - Stock Titan
Henry Schein (HSIC) EVP Mlotek surrenders shares for tax and issuer - Stock Titan
Henry Schein (NASDAQ: HSIC) COO logs stock disposals tied to award vesting - Stock Titan
Henry Schein (NASDAQ: HSIC) CEO Bergman reports stock sales and share disposals - Stock Titan
Henry Schein (NASDAQ: HSIC) exec uses shares to cover tax withholding - Stock Titan
Henry Schein, Inc. $HSIC Shares Sold by Laurel Wealth Advisors LLC - MarketBeat
Henry Schein to Participate in Upcoming Investor Conferences in March - Bluefield Daily Telegraph
Stanley Bergman disposes HSIC stock (NASDAQ: HSIC) — Form 144 notice - Stock Titan
Henry Schein (HSIC) CEO Lowery files Form 3 showing no share ownership - Stock Titan
Henry Schein, Inc. (HSIC): Investor Outlook With A 7.5% Upside Potential - DirectorsTalk Interviews
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Will Strong Q4 2025 Results and Impairment Charge Reframe Henry Schein's (HSIC) Investment Narrative? - simplywall.st
Foyston Gordon & Payne Inc Lowers Stock Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Dental Polishers Brownie 0411 Silicon PolisherHenry Schein Dental Polishing Brush Dental - hotelier.com.py
Henry Schein, Inc. $HSIC Shares Sold by American Century Companies Inc. - MarketBeat
Stanley Bergman Sells 10,785 Shares of Henry Schein (NASDAQ:HSIC) Stock - MarketBeat
Insider Selling: Henry Schein (NASDAQ:HSIC) CEO Sells 38,346 Shares of Stock - MarketBeat
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein (HSIC) CEO Bergman reports sale of 49,131 company shares - Stock Titan
Henry Schein, Inc. $HSIC Shares Purchased by Artisan Partners Limited Partnership - MarketBeat
Henry Schein Names New CEO - HME Business
How Henry Schein (HSIC) Story Is Shifting As Analysts Reassess Growth And Valuation - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC) - The Globe and Mail
Henry Schein (HSIC): UBS Maintains "Neutral" Rating, Price Targe - GuruFocus
JPMorgan Chase & Co. Increases Henry Schein (NASDAQ:HSIC) Price Target to $92.00 - MarketBeat
Henry Schein Reports Strong Q4 Earnings Exceeding Expectations - Intellectia AI
Henry Schein (NASDAQ:HSIC) Price Target Raised to $88.00 at Mizuho - MarketBeat
These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results - Benzinga
Henry Schein (NASDAQ:HSIC) Given New $61.00 Price Target at Morgan Stanley - MarketBeat
Wells Fargo & Company Issues Positive Forecast for Henry Schein (NASDAQ:HSIC) Stock Price - MarketBeat
Research Alert: CFRA Maintains Sell Rating On Shares Of Henry Schein Inc. - 富途牛牛
Barrington Adjusts Price Target on Henry Schein to $97 From $79, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Price Target on Henry Schein to $87 From $79, Maintains Neutral Rating - marketscreener.com
Henry Schein, Inc. (NASDAQ:HSIC) Q4 2025 earnings call transcript - MSN
JPMorgan Adjusts Price Target on Henry Schein to $92 From $78, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Henry Schein to $61 From $58, Maintains Underweight Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90 - marketscreener.com
Baird Adjusts Price Target on Henry Schein to $104 From $100 - marketscreener.com
Leerink Partners Adjusts Price Target on Henry Schein to $87 From $75 - marketscreener.com
Henry Schein, Inc. (NASDAQ:HSIC) Q4 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Adjusts Price Target on Henry Schein to $87 From $76 - marketscreener.com
Stifel Adjusts Price Target on Henry Schein to $84 From $72 - marketscreener.com
Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Delcath Systems (DCTH) and Certara (CERT) - The Globe and Mail
Decoding Henry Schein Inc (HSIC): A Strategic SWOT Insight - GuruFocus
Henry Schein Balances Strong Growth With Margin Pressure - TipRanks
Henry Schein (HSIC) Margin Stays Near 3% And Tests Premium P/E Narrative - simplywall.st
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.03%
2.68%
자본화:
|
볼륨(24시간):